Movement Disorders in MOGAD: A Systematic Review
Medicina · 04.04.2026 · 62 (4) · 693
DOI: 10.3390/medicina62040693 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medicina, online erschienen am 04.04.2026. Verfasst von Stefania Kalampokini und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Movement Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and objectives: Movement disorders are an underrecognized phenomenon in Myelin Oligodendrocyte Glycoprotein-Associated Disease (MOGAD). The aim of this paper was to summarize all movement disorders previously described in MOGAD. Materials and Methods: We conducted a systematic literature search in PubMed, Web of Science, and Scopus in English, focusing on patients with MOGAD exhibiting a movement disorder, i.e., ataxia, tremor, dystonia, parkinsonism, chorea, athetosis, myoclonus, ballism, tics, stereotypies, dyskinesia.
Results
We included 58 studies, with a total of 91 patients with MOGAD and a movement disorder (45.6% male, 54.4% female). Movement disorders had a mean latency of 2.1 years (±6.9, 0–42) after MOGAD onset; however, they could be the presenting feature (in approximately 70% of cases), especially in pediatric patients. Cerebellar ataxia was the most common movement disorder, occurring in 77 patients (84.6%). Tremor, postural and/or kinetic, was the second most common movement disorder (15%). Dystonia was reported in 8.8%, presenting as cervical, or limb dystonia or stereotyped dystonic episodes. Myoclonus and hypokinetic movement disorders were rare. Subcortical (in 60%), brainstem and cerebellar lesions (in 50% respectively) were the most common imaging findings. The most common accompanying symptoms were encephalopathy, fever and headache. Approximately half of the patients made a full recovery, and the other half showed a significant improvement in the movement disorder after immunomodulatory treatment, most commonly steroids.
Conclusions
The new onset of a movement disorder, especially ataxia, in a young patient should prompt the search for MOGAD or can indicate a relapse in patients with an established diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
- Medical School, University of Cyprus, Nicosia 1678, Cyprus.
- 1st Department of Neurosurgery, AHEPA University Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
ORCID-Profile: Stefania Kalampokini, Antonis Frontistis, Iraklis Keramidiotis, Vasilios K Kimiskidis, Effrosyni Koutsouraki
Zitieren
APA
Kalampokini, S., Frontistis, A., Pilavas, A., Keramidiotis, I., Arnaoutoglou, M., Kimiskidis, V. K., & Koutsouraki, E. (2026). Movement Disorders in MOGAD: A Systematic Review. Medicina, 62(4), 693. https://doi.org/10.3390/medicina62040693
Vancouver
Kalampokini S, Frontistis A, Pilavas A, Keramidiotis I, Arnaoutoglou M, Kimiskidis VK, et al. Movement Disorders in MOGAD: A Systematic Review. Medicina. 2026;62(4):693. doi:10.3390/medicina62040693
BibTeX
@article{Kalampokini2026,
author = {Kalampokini, Stefania and Frontistis, Antonis and Pilavas, Antonis and Keramidiotis, Iraklis and Arnaoutoglou, Marianthi and Kimiskidis, Vasilios K and Koutsouraki, Effrosyni},
title = {Movement Disorders in MOGAD: A Systematic Review},
journal = {Medicina},
year = {2026},
volume = {62},
number = {4},
pages = {693},
doi = {10.3390/medicina62040693}
}
EUVIMED